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Epidermolysis Bullosa Simplex in Scotland Caused
by a Spectrum of Keratin Mutations
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Carrie S. Shemanko1,5, David U. Baty3, Michael J. Tidman2 and E. Birgitte Lane1
Epidermolysis bullosa simplex (EBS) is an inherited skin disorder caused by mutations in keratins K5 (keratin 5)
and K14 (keratin 14), with fragility of basal keratinocytes leading to epidermal cytolysis and blistering. Patients
present with widely varying severity and are classified in three main subtypes: EBS Weber–Cockayne (EBS-WC),
EBS Ko¨bner (EBS-K), and EBS Dowling–Meara (EBS-DM), based on distribution and pattern of blisters. We could
identify K5/K14 mutations in 20 out of the 43 families registered as affected by dominant EBS in Scotland; with
previous studies this covers 70% of all Scottish EBS patients, making this the most comprehensively analyzed
EBS population. Nine mutations are novel. All mutations lie within five previously identified rod domain
hotspots and the severest blistering was associated with mutations in the helix boundary motifs. In some cases,
the same mutation caused symptoms of EBS-WC and/or EBS-K, both within and between families, suggesting a
contribution of additional factors to the phenotype. In some patients, no mutations were found in K5, K14, or
K15, suggesting involvement of other genes. The results confirm that EBS is best considered as a single disorder
with a spectrum of phenotypic variations, from severe EBS-DM at one extreme to mild EBS-WC at the other.
Journal of Investigative Dermatology (2007) 127, 574–580. doi:10.1038/sj.jid.5700571; published online 12 October 2006
INTRODUCTION
Epidermolysis bullosa simplex (EBS) is an inherited skin
disorder that is characterized by skin fragility and blistering.
Recent estimates indicate the prevalence in Scotland to be at
least one in 30,000 individuals (Horn et al., 1997; Horn and
Tidman, 2002). Most cases of EBS are inherited in an
autosomal dominant manner and are caused by defects in
the genes encoding the intermediate filament proteins keratin
5 (K5) and keratin 14 (K14) (Irvine and McLean, 1999). EBS is
a disorder of widely varying severity; patients are normally
classified into three groups according to clinical features such
as distribution, pattern, and severity of blistering. A minority
of EBS patients have the Dowling–Meara variant of EBS (EBS-
DM, OMIM 131760), the severest form, characterized by
widespread, herpetiform (clustered) blistering. EBS-DM is
diagnosed ultrastructurally by the presence of keratin
aggregates in basal keratinocytes (Anton-Lamprecht and
Schnyder, 1982). Most EBS patients are affected by the
milder Weber–Cockayne variant of EBS (EBS-WC, OMIM
131800), characterized by seasonal non-scarring blistering,
worst in the summer months but confined to hands and feet
(Weber, 1926; Cockayne, 1938). Young EBS-WC patients
may blister at other body sites (Eady, 1990). Another group of
patients report seasonal blisters at widespread sites of friction,
particularly under tight clothing such as waistbands and
collars, and these clinical features characterize the Ko¨bner
form of EBS (EBS-K, OMIM 131900) (Ko¨bner, 1886).
Although many patients can be classified like this, differential
diagnosis is often difficult and imprecise (Eady, 1990). Severe
EBS can be hard to distinguish from junctional and dystrophic
EB during the neonatal period, with electron microscopy
usually required to determine the cleavage plane in the skin
(Eady, 1990). The identification of mutations in keratins K5
and K14 as the cause of most cases of EBS has added a
molecular dimension to the diagnosis of this condition.
Keratins are the intermediate filament cytoskeleton pro-
teins in epithelial cells; K14 (a type I keratin) and K5 (its type
II partner) are specifically expressed in the basal cells of
stratified epithelia. The heteropolymeric keratin filament
network is assembled in the cytoplasm from type I and type
II keratin proteins, which have a common structure of a
discontinuous a-helical rod domain flanked by non-helical
head and tail domains. More than 96 different pathogenic
mutations have now been documented in K5 and K14 (see
http://www.interfil.org, Cassidy et al., 2002), clustered in
specific regions or hotspots along the protein molecule
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(reviewed by Lane and McLean, 2004). There is some
correlation between the position and nature of the mutation
and the severity of the disease. The helix boundary motifs at
the beginning and end of the rod domain are critical for
normal filament formation (Hatzfeld and Weber, 1991), and
mutations here cause the severest form of EBS (EBS-DM),
particularly the mutations in the helix initiation motif of K14.
The phenotype/genotype correlation for EBS-WC and EBS-K
is less clearcut.
In a recent survey in Scotland, detailed phenotypic
information was reported on individuals from 33 of the 43
families known to be affected by EBS (Horn and Tidman,
2000). That study suggested that phenotypic characteristics
could not clearly segregate patient families into the simple
diagnostic groups of EBS-DM, EBS-K, or EBS-WC. We have
therefore undertaken molecular analysis of keratin mutations
in this population to re-evaluate the diagnostic criteria. Here,
we report pathogenic mutations in 20 families from this
Scottish cohort and provide evidence that EBS-DM, EBS-K,
and EBS-WC represent different points on a spectrum of
phenotypic variation of the same disorder. The causative
mutations in another five Scottish kindreds have already been
described (Rugg et al., 1993; Shemanko et al., 2000; Wood
et al., 2003). Combining present and previous studies of this
and other EB disorders in Scotland, the Scottish population
now becomes the most comprehensively studied EB popula-
tion to date.
RESULTS
Phenotypic observations
From the 27 families analyzed, 123 affected individuals were
clinically assessed. Full details are given in Table S1. An
unequivocal EBS-DM phenotype was observed in seven
individuals from six families (families 2–6, 19 in Table S1).
The eldest, aged 48 years, had an affected son for whom no
clinical information is available. The youngest, aged 3 weeks,
were monozygotic twins. The remaining EBS-DM patients
were unrelated and had no family history of EBS. Ultra-
structural analysis was not undertaken in family 2, but in skin
samples from one twin (family 4) and each of the remaining
EBS-DM individuals, keratin aggregates were present and the
cleavage plane was through the cytoplasm of the basal
keratinocytes.
The remaining 116 patients (aged 1–78 years) from 21
families did not show Dowling–Meara phenotypes. Their
blistering showed seasonal variation, being most severe
during warm weather. Five patients had no previous family
history of blistering. The youngest of these was 12 years old
(family 12), but the four older patients (families 1, 7, 18, and
26) each had affected children. In the 16 remaining families,
there was a history of EBS in at least two generations and an
autosomal dominant pattern of inheritance. Of the EBS
patients exhibiting non-DM phenotypes, all experienced
painful blisters on the feet; 91 (78%) also suffered from
blisters on the hands. Sixty-eight individuals (58%) blistered
at additional sites, usually under waistbands, collars, ribbing
of socks, necklaces, or edges of nappies. Oral blistering and
nail dystrophy also occurred in a minority (around 20%) of
patients. There were six families in which the phenotype was
consistently of the Weber–Cockayne (EBS-WC) type (i.e.
blisters were restricted to the feet and/or hands), and five in
which all affected individuals had symptoms consistent with
the Ko¨bner (EBS-K) phenotype (i.e. seasonal blistering at sites
in addition to hands and feet).
With the exception of family 7, all families showing a
homogenous phenotype were small, none having more
than four affected individuals. In each of the remaining
10 families, there was a mixture of EBS-WC and EBS-K
phenotypes, as defined by classical criteria used previously
(Horn and Tidman, 2000). Many patients reported reduced
severity of their blisters with increasing age, and in two small
mixed-phenotype kindreds, unambiguous EBS-K was seen
only in the younger patients (families 1 and 8). In several of
the remaining mixed-phenotype families, the EBS-K pheno-
type was seen in adults over 50 years old as well as in
younger patients.
Identification of keratin mutations
Mutations in keratin genes were found in 20 of the 22 families
described here for the first time (Figure 1; Table S1).
Eighteen different sequence variants were identified in
these families, of which nine have not been reported
previously. These mutations were not present in DNA
samples from more than 50 unrelated individuals, indicating
that they were not common polymorphisms. Fourteen
mutations affected K14 and six affected K5. All the mutations
occurred in or close to previously identified mutational
‘‘hotspots’’.
Of the six families with EBS-DM, five had mutations in the
helix initiation motif K14:Leu122Phe (family 2), Arg125Cys
(families 3 and 4), and Arg125His (families 5 and 6).
The sixth had a mutation in the helix initiation motif of K5,
Ser181Pro (family 19). We have reported the mutations in
families 5 and 19 elsewhere (Shemanko et al., 2000); the
other mutations have been seen by other groups.
Of the non-DM patients, the one in family 12 had the K14
mutation Arg148Cys (Wood et al., 2003). This appeared to be
a de novo mutation as no other family member was affected
by blistering; the phenotype was very mild with blisters
confined to the feet. The mutations in families 13
(K14:V270M) and 22 (K5:R331C) have also been reported
previously (Rugg et al., 1993). In the course of this study two
more families (14 and 23) were found to carry the same
alterations, respectively. It is not known whether families 22
and 23 are related, although there is no indication of
common ancestry in their respective family histories.
Currently, these two mutations have only been reported in
families from Scotland.
Three families were found to have previously reported
mutations that affected codon 133 of K14. The mutation
K14:V133M was identified in affected individuals from
families 8 and 9; this mutation was also reported to cause
EBS-WC in a multi-generation Polish family (Hamada et al.,
2005). Most affected individuals in our families had mild
blistering consistent with EBS-WC, although one child (aged
20 months) showed more widespread blistering. Haplotype
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analysis of families 8 and 9, using polymorphisms in exon I
of K14, suggested that the mutations had arisen indepen-
dently in the two families. The mutation K14:V133L was
identified in family 10. This mutation has been reported to
cause mild EBS-WC (Liovic et al., 1997; Csikos et al., 2004),
although most individuals in our study had a more severe
phenotype.
Family 16 had the mutation K14:R388C. This mutation has
been reported to cause a mild phenotype blistering confined
to acral regions (Chen et al., 1995) and a similar mild
phenotype was also seen in our family. Finally, affected
members from family 20 were found to have a mutation in K5
(K5:N193). This mutation has been reported in an Irish
kindred with EBS-WC (Humphries et al., 1996), but our
family had a more severe phenotype and most affected
individuals had symptoms of EBS-K.
Novel mutations in K14
The five novel mutations identified in K14 were all associated
with phenotypes not typical of EBS-DM, although there was
considerable variability both within and between families.
Four mutations, Lys116Glu (family 1), Tyr129Cys (family 7),
Val133Ala (family 11), and Leu418Val (family 17), were
associated with relatively severe blistering and most indivi-
duals in these families had lesions at other body sites besides
hands and feet. All these mutations altered conserved amino
acids in the helix boundary regions. Blistering was particu-
larly extensive in family 7. The children in this family had
herpetiform blisters resembling EBS-DM, but onset of
blistering was delayed and showed seasonal variation more
suggestive of EBS-K. The mutation K14:Ile377Thr was
identified in family 15, introducing a sequence change lying
close to the stutter region in helix 2B, and giving an EBS-WC
phenotype.
Novel mutations in K5
Four novel mutations were found in K5. The mutation
Glu170Gly lies at the boundary of helix 1A with the head
domain, and in family 18 this was found associated with a
relatively severe phenotype with blistering at sites of high
friction, plus oral lesions and nail dystrophy in the younger
patient. Two different novel K5 mutations were found in
families 24 and 25, both of which were in the C-terminal
portion of helix 2B. An Ala428Val mutation (family 24)
resulted in a moderately severe phenotype including oral
lesions, whereas a mutation causing the conservative amino-
acid change Ile467Leu, in the highly conserved helix
termination motif, gave a relatively mild phenotype with
blistering mostly confined to hands and feet.
Family 21 was affected by EBS through three generations
(Supplementary Material, Figure S1). The phenotype of
disease in this family was extremely variable between
individual family members. Two individuals (II.1 and III.2)
were particularly severely affected, and ultrastructural
examination showed the presence of keratin aggregates in
the one individual examined. However, the phenotype was
unlike Dowling–Meara in many ways: blisters were not
herpetiform, although they did occur outside the hands and
feet; the disorder showed late onset (after one month of age)
and affected individuals reported seasonal variation of
blistering. Thus, they were classified as Ko¨bner EBS. The
remaining affected individuals had a much milder phenotype
more typical of Weber–Cockayne EBS. Mutation analysis of
DNA from the two severely affected individuals (II.1 and III.2)
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Figure 1. A schematic diagram of K5 and K14 to show the nature and position of mutations identified in EBS patients in Scotland. The rod domain of
both keratins (wide rectangles) is flanked by heads and tails (solid line) and in K5 only, additional helical regions (H1 and H2 (narrow rectangles)); helical
subdomains 1A, 1B, 2A, and 2B and non-helical linkers L1, L12, L2 are indicated. The conserved helix boundary motifs are represented by the shaded boxes
at the beginning of helix 1A and the end of helix 2B and the stutter by the vertical line in helix 2B. Gray ovals denote EBS-DM mutations and white ovals
EBS-K and/or EBS-WC.
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revealed a heterozygous change in the L12 region of K5 that
resulted in the alteration Asn329Ser. The L12 is a hotspot for
pathogenic mutations and a different mutation in the same
codon has been reported to cause EBS-WC (Chan et al.,
1993), although mutations in this region are not usually
associated with keratin filament aggregates.
No K5/K14 mutation was found in family members with
less severe disease, in spite of extensive sequencing of the
whole coding region and most of the introns of KRT5 and
KRT14. The identity of the putative second mutation in this
family thus remains to be identified. It is possible that one
allele was deleted, although the asymptomatic heterozygote
parents of K14-null patients seen elsewhere suggests this is
unlikely.
No evidence for K15 mutations
In addition to the individuals in family 21 described above,
no pathogenic mutations in K5 or K14 could be found in
families 26 and 27. K15 sequencing was therefore under-
taken. K15 is a type I keratin that is expressed by basal
keratinocytes of the epidermis; although its expression is
more restricted than K14, it is another potential candidate
gene for EBS (Waseem et al., 1999). The entire coding
sequence of the KRT15 gene including intron/exon bound-
aries was sequenced in affected individuals from families 21,
26, and 27, but no mutation was found. It was not possible to
perform linkage analysis on these families because of the
small number of available samples and therefore we could
not exclude the keratin loci as candidate regions for the
disease.
DISCUSSION
This study documents the causative K5 and K14 mutations in
20 out of the 43 families affected by dominant EBS in
Scotland, which together with five previously reported
mutations (Rugg et al., 1993; Shemanko et al., 2000; Wood
et al., 2003) accounts for 70% of the known EBS cases in the
Scottish population. This may be the first attempt to
document such a high proportion of all the mutations within
a defined population. In addition, because the phenotypic
information was gathered by a single clinician (H.M.H.) and
classified according to defined criteria, this study is less
susceptible to variations in the classification of symptoms and
thus phenotype/genotype comparisons are more likely to be
meaningful and we are already able to draw some useful
conclusions.
Diverse K5/K14 mutations underlie EBS in the Scottish
population
A striking finding of this study is the diversity of keratin
mutations that underlie EBS in the Scottish population. Out
of 25 mutations, only five were seen more than once, and
in these cases there was no evidence of common ancestry
between the families concerned, suggesting that each
family may represent an independent mutational event. All
the mutations identified are single nucleotide changes
predicted to result in amino-acid substitutions. Nine
mutations reported here are described for the first time and
a further four mutations have so far only been found in this
population.
Distribution of mutations
All the mutations observed here occurred within four regions
previously identified as mutation ‘‘hotspots’’, namely the start
of helix 1A, the L12 linker domain, and two clusters in helix
2B (Lane, 1994). Overall, the ratio of K5 to K14 mutations in
EBS, and the distribution of mutations within these hotspots,
is not significantly different from reports published previously
(Figure 2; www.interfil.org, Cassidy et al., 2002). Almost half
of all the mutations alter residues in helix 1A of K14, and at
least half of these (7/12) resulted in non-EBS-DM phenotypes.
The proportion of mutations in this region associated with the
milder forms of EBS was higher than expected from the
published literature, possibly reflecting an earlier bias
towards reporting and diagnosis of the more severe pheno-
types. Families with mild EBS do not always seek medical
attention and therefore mutations associated with the less
severe forms of EBS are less likely to be identified (Eady,
1990).
One notable difference between this group and the
published data is the absence of mutations in the head
domain of K5. Mutations in the H1 part of the head domain
are a common cause of EBS-WC elsewhere, and we have
observed similar mutations in individuals from other parts of
the UK (Rugg EL, Smith FJD, Navsaria H, Morley SM,
Wojnarowska F, Leigh IM, Lane EB (1998) Skin fragility in
Weber–Cockayne EBS caused by mutations in epidermal
keratins. Br J Dermatol 129:486 (abstract).). The common K5
Ile161Ser mutation has been found in several families and it
is possible that in some cases the mutation has been passed
down from a common founder. If this has occurred then the
true frequency of de novo mutations will be lower than
currently thought, and the probability of this mutation
occurring in the Scottish population would be correspond-
ingly lower. A second mutation in the head domain of K5,
Pro25Leu, has been linked to a rare variant of EBS in which
blistering is accompanied by mottled pigmentation (e.g., see
Uttam et al., 1996). There were no cases of this form of EBS in
our cohort.
Mutations have been reported that alter amino acids close
to the helix discontinuity or ‘‘stutter’’ in helix 2B of K14
(Bonifas et al., 1991; Chen et al., 1993, 1995; Hachisuka
et al., 1995). We also observed mutations in that region here.
Two mutations have also been identified in a similar region of
K5 (Yasukawa et al., 2002; Schuilenga-Hut et al., 2003). The
identification of a third K5 mutation in this region in one of
our families (family 24) confirms this as a true hotspot cluster
site for pathogenic mutations (Lane, 1994). This means that
there are now corresponding mutations in all hotspot regions
common to the rod domains of K5 and K14. These regions
appear to be sensitive to sequence variations, suggesting that
they are critical functional sites in the keratin filament and
that alterations at these sites lead to disturbances in keratin
cytoskeleton function. The symmetrical nature of the hotspots
between K5 and K14 suggests an equivalence of function of
these regions in the two molecules.
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Phenotype/genotype correlation
Within families with non-DM EBS (i.e. EBS-K or EBS-WC), a
single mutation can be associated with a spectrum of
phenotypes varying from seasonal blistering, confined
exclusively to the hands and feet in some individuals, to
more widespread blistering (but falling short of the severity of
the Dowling–Meara phenotype) in their affected relatives. We
consistently noted this variability in large pedigrees with
many affected individuals (Table S2, e.g. family 13 and family
20). In some cases, increasing age is associated with
improvement of the phenotype (Horn and Tidman, 2000),
and it is therefore important to note the age at which patients
are diagnosed. Age not withstanding, however, it is clear
from this study that a single mutation can be associated with a
variety of phenotypes.
Mutations that affect arginine 125 at the start of helix 1A in
K14 are the most commonly reported cause of EBS-DM
(Figure 2). These were also the major cause of this form of
EBS in the Scottish population. Mutations affecting adjacent
residues also caused severe blistering but these cases were
not always unequivocally diagnosed as the Dowling–Meara
form. In one case described here (family 2), the affected
individual had the mutation K14:Leu122Phe and clinical
features of EBS-DM, although this mutation, in a Japanese
family, has been reported to cause the Ko¨bner form of the
disease (Yamanishi et al., 1994). As no skin biopsy was
available from our patient, it was not possible to confirm
whether our patient showed the keratin aggregates that are
the ultrastructural diagnostic criterion of EBS-DM. Variable
phenotypes have even been seen between related individuals
carrying the K14 Arg125Cys mutation (Sasaki et al., 1999):
one individual had typical EBS-DM symptoms, whereas
others had milder symptoms more typical of EBS-WC. The
apparent differences in phenotype/genotype correlation may
reflect variation in reporting of clinical phenotype but might
also suggest that other factors, in addition to the keratin
mutation, influence the phenotype of EBS-DM.
In a number of cases, different mutations in the same
codon resulted in different phenotypes. For example, a
mutation in codon 129 of K14 (Tyr129Asp) was previously
reported in severe EBS-DM (Chan et al., 1996), whereas in
one of our families, a different mutation in the same codon,
K14:Tyr129Cys, was associated with a phenotype sharing
features of both EBS-DM and EBS-K. Similarly, Irvine et al.
(1997) described a mutation in K5 (Ile467Thr) in a patient
with EBS-DM), whereas the K5:Ile467Leu patients described
had milder phenotypes with most individuals having only
blistering on hands and feet. It is not clear from these
individual cases how much the nature of the amino-acid
substitution contributes to the overall severity of disease and
how much is due to other genetic and/or environmental
factors. Homology structure predictions of the effects of
mutations on helix 1A show that different changes at the
same relative position in the helix can produce significantly
K14
K5
1 2 3
L1 L12 L2
1A 1B 2A 2B I = 1 family
4 5 6
Figure 2. Schematic diagram showing the distribution of identified dominant missense mutations, and single amino-acid deletions along the K5 and K14
polypeptides. Mutations identified in the Scottish population (this paper; also Rugg et al., 1993; Shemanko et al., 2000; Wood et al., 2003) are shown below the
relevant keratin, and previously published mutations, excluding those found in Scotland, are shown above. Height of bars is proportional to number of separate
mutations; shortest bar represents one family/case. The length of keratin domains is drawn to scale (proportional to numbers of amino acids in each domain).
Mutations associated with the Dowling–Meara phenotype are in red, those associated with non-EBS-K and/or EBS-WC in blue, and EBS with mottled
pigmentation mutations shown in green. The numbered arrows indicate previously identified mutation ‘‘hotspots’’ (Lane, 1994).
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different distortions in the keratin structure (Liovic et al.,
2001).
EBS patients with no detectable K5 or K14 mutations
It is evident from the published literature that mutations in the
KRT5 and KRT14 genes encoding K5 and K14 are the major
cause of EBS. However, there are a residual number of
patients in which mutations in the coding regions of K5 and
K14 may not be the reason for the tissue fragility. We have
been unable to find K5/K14 mutations in three of the 27
families analyzed, and no evidence for mutations in K15
either. One family showed a predicted pathogenic keratin
sequence variant in only some of the affected patients; in the
other two, no mutations were found. From all the UK EBS
patients whose K5 and K14 coding sequences we have
analyzed completely, we have been unable to detect
mutations in approximately 22% of the cases (E.B. Lane,
personal observation). This is significantly lower than the
50% suggested by Chen et al. (1995), although that study
employed an initial screening procedure (single-strand
conformation polymorphism analysis) that may have missed
some mutations. Our study suggests that in the Scottish
population, mutations in non-keratin genes may account for
less than 10% of EBS cases.
No splice site or premature termination mutations were
identified in this study, although the KRT5 and KRT14 genes
were extensively sequenced (including intron boundaries). It
is still possible that an undetected intronic mutation might
affect a splice site leading to aberrant protein expression. The
effects of sequence variations in introns can be difficult to
determine and usually require analysis of mRNA from a tissue
sample. This was not possible in the current study as biopsies
are not felt to be clinically justified for mild EBS cases.
Mutations in non-keratin genes may also underlie the EBS in
these cases; the hemidesmosome proteins plectin (for
example, Smith et al., 1996), BP180/collagen XVII (Huber
et al., 2002), and b4 integrin (Jonkman et al., 2002) have
already been implicated in EBS-like keratinocyte fragility.
Detailed electron microscopy could help identify non-keratin
target genes, but as discussed skin biopsies are rarely taken
from mild EBS cases.
In summary, mutations in keratin genes are confirmed as
the major cause of EBS in the Scottish population. This is now
the most extensively documented population for EB dis-
orders. With 70% of EBS-affected individuals in Scotland
analyzed, K5/K14 mutations appear causative in around 90%
of cases. The severity of the disease is primarily determined
by the position of the mutation in the protein, and can be
further influenced by the nature of the mutation, and also by
other genetic or epigenetic factors still unidentified. This
study reinforces the hypothesis that EBS is best thought of as a
single disorder, of which EBS-DM is at one end of a spectrum
of phenotypic variations that include EBS-K and EBS-WC.
MATERIALS AND METHODS
Scottish EBS patients were identified during compilation of the
DEBRA UK EB Register and their clinical features were recorded in a
standardized manner. Patients were identified (Horn et al., 1997)
from a database at the Royal Infirmary of Edinburgh, and from
enquiries to all Scottish dermatologists and to general practitioners in
the Lothian region. Relatives of probands were sought out and
clinically assessed. Patients were classified into three groups, EBS-
DM, EBS-K, and EBS-WC, based on clinical features including site
and distribution of blisters, age of onset of blistering, and seasonal
variations in frequency of blistering according to previously
described criteria (Horn and Tidman, 2000). In cases of diagnostic
doubt, skin biopsies were taken for ultrastructural examination and
determination of the cleavage plane within the epidermis.
Blood samples for DNA extraction were taken from affected
individuals in 28 of the 43 Scottish families affected by EBS. For
details of methods used for DNA analysis, see Supplementary
Material. All aspects of this study were carried out in accordance
with the Declaration of Helsinki Principles and complied with
requirements of the local institutional ethical review board. All
individuals gave their fully informed consent for blood sample
collection and inclusion in the database.
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